Skip to content
★ Sign in to follow
CC

Curacle Co.,Ltd. Stock: price and insider trades · South Korea

큐라클

KR·Mcap ₩210.3BHealth Care

No insider purchase over the last 90 days. The latest, by 황용, was filed 10 Jun 2026.

Curacle Co.,Ltd.: what insiders have been doing

Curacle Co.,Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). 7 insiders have disclosed 7 filings since 1 November 2025.

No insider sold shares on the market over the period. Instead, the filings list 6 purchases, made by 6 insiders. The totals do not cover 6 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 3 board members and 3 senior executives.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 7 filings here. The full history, which starts in 2021, counts 25 purchases against 7 sales.

The last insider purchase was made public on 10 June 2026, 152 days ago.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
34
Thresholds
n/a
Buy Volume
€358,535
25 ops. · all time
Sell Volume
€13M
7 ops. · all time

Who traded when

BuySale
김정한1 buy
이원일1 buy
최동훈1 buy
최재진1 buy
추연성1 buy
표정인1 buy

+1 other insider

Fundamental score
Ranked 19,150 of 26,913 companies
37.3
score / 100
Value
19
Quality
55
FCF yld-6.4%
Earn yld-8.6%
EV/EBITDA·
ROE-23%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩9,490
Analyst consensus
·
Income statement
Revenue₩7.1M
Gross profit₩7.1M100% margin
EBITDA-₩15.9B-223960% margin
Net income-₩18.1B-92.1% margin
Valuation
Beta2.10
Balance sheet & cash
Market cap₩210.3B
Total debt₩13.4B
Free Cash Flow-₩13.5B
Debt / Equity24%
Profitability & ownership
ROE-22.6%
ROA-10.5%
% insiders17.6%
% institutions0.6%
Last declaration on 10 June 2026
Declarations34 total
  • ▲
    이사Executives(filed)
    €26kest.0DART
    4,000 sharesShareKRXDART:20260610000245
    Canonical exit: 8 Sept 2026 (T+90)
  • ▲
    이사Executives(filed)
    €128kest.0DART
    20,000 sharesShareKRXDART:20260610000230
    Canonical exit: 8 Sept 2026 (T+90)
  • ▲
    기타비상무이사Executives(filed)
    €64kest.0DART
    10,000 sharesShareKRXDART:20260610000237
    Canonical exit: 8 Sept 2026 (T+90)
  • ▲
    상무Executives(filed)
    €55kest.0DART
    8,608 sharesShareKRXDART:20260610000238
    Canonical exit: 8 Sept 2026 (T+90)
  • ▲
    상무Executives(filed)
    €51kest.0DART
    8,000 sharesShareKRXDART:20260610000241
    Canonical exit: 8 Sept 2026 (T+90)
  • ▲
    상무Executives(filed)
    €32kest.0DART
    5,000 sharesShareKRXDART:20260610000239
    Canonical exit: 8 Sept 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    사외이사Executives(filed)
    €2,254est.0DART
    600 sharesShareKRXDART:20250926000108
    Canonical exit: 25 Dec 2025 (T+90)
  • ▼
    Executives
    €11.4Mest.0DART
    2,873,335 sharesKRXDART:20240726000569
  • ▼
    Executives
    €1.3Mest.0DART
    160,000 sharesShareKRXDART:20240117000173
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20230316001172
    Canonical exit: 14 Jun 2023 (T+90)
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20221215000409
    Canonical exit: 15 Mar 2023 (T+90)
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20221130001875
    Canonical exit: 28 Feb 2023 (T+90)
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20221130001930
    Canonical exit: 28 Feb 2023 (T+90)
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20220805000260
    Canonical exit: 3 Nov 2022 (T+90)
  • ▼
    Executives(filed)
    0DART
    2,873,335 sharesKRXDART:20220729000581
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20220418000423
    Canonical exit: 18 Jul 2022 (T+90)
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20220418000424
    Canonical exit: 18 Jul 2022 (T+90)
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20220418000425
    Canonical exit: 18 Jul 2022 (T+90)
  • ▼
    Executives(filed)
    0DART
    2,873,335 sharesKRXDART:20220408002664
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20211213000392
    Canonical exit: 13 Mar 2022 (T+90)
  • ▼
    Executives(filed)
    0DART
    2,873,335 sharesKRXDART:20211213000374
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20210909000198
    Canonical exit: 8 Dec 2021 (T+90)
  • ▲
    이사회 의장Executives(filed)
    0DART
    ShareKRXDART:20210909000200
    Canonical exit: 8 Dec 2021 (T+90)

25 of 34 declarations

About Curacle Co.,Ltd.

큐라클 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations